Keywords: imclone, c225, plus, taxol, systems, begun, additional

ImClone's C225 Plus Taxol

Article | 11 March 1996

Print This

- ImClone Systems has begun an additional Phase Ib/IIa clinical trial of its lead cancer therapeutic, C225, in combination with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in